On the recordSeptember 6, 2016
the use of quality metrics with regard to bringing down the pain surveys, bringing down the numbers, inadvertently incentivized physicians to push opiate medication
Source
congress.govEditor's note · Context
Kuster discusses unintended consequences of quality metrics leading to increased opioid prescriptions.
Share & report
More from Annie Kuster
Apr 25, 2023
I want to thank the Chair. It is great to work with you, Chairman Guthrie and Ranking Member Eshoo and Congressman Buddy Carter, to introduce this legislation that brings transparency to pharmacy benefit manager operations and lowers costs…
Mar 27, 2023
I am reintroducing my bipartisan bill, Increasing Transparency in Generic Drug Applications Act of 2022.
Mar 27, 2023
Patients rely on supports like the 340B program, which provides discounts on essential prescription drugs to vulnerable communities.
May 24, 2023
Madam Chair, I rise today to speak in opposition to H.R. 467, the HALT Fentanyl Act. The fentanyl crisis has touched every community across our State and country. We need to take serious, bipartisan action to address this epidemic and save…
Other voices in this conversation
